Table 1 Descriptive Statistics for Women in the Comparison Group and Women with Breast Cancer at Baseline (Time 1) and After Completion of Chemotherapy (Time 2)
From: Tryptophan degradation in women with breast cancer: a pilot study
| Â | n | mean | median | std | stderr | 95% LCL | 95% UCL |
|---|---|---|---|---|---|---|---|
Comparison Group (Benign Breast Biopsy) | |||||||
Kynurenine (μmol/l) | 24 | 1.98 | 1.92 | 0.43 | 0.09 | 1.79 | 2.16 |
Tryptophan (μmol/l) | 24 | 52.89 | 51.90 | 10.44 | 2.13 | 48.48 | 57.30 |
Kyn/Trp ratio (μmol/l μmol) | 24 | 3.81 | 3.81 | 0.88 | 0.18 | 3.44 | 4.18 |
Tyrosine (μmol/l) | 24 | 81.70 | 76.63 | 26.20 | 5.35 | 70.64 | 92.77 |
Age (years) | 24 | 49.96 | 48.50 | 10.98 | 2.24 | 45.32 | 54.60 |
Breast Cancer Group | |||||||
Time 1 (Baseline - Prior to Induction of Chemotherapy) | |||||||
Kynurenine (μmol/l) | 33 | 2.27 | 2.05 | 1.13 | 0.20 | 1.87 | 2.67 |
Tryptophan (μmol/l) | 33 | 48.86 | 47.62 | 10.68 | 1.86 | 45.08 | 52.65 |
Kyn/Trp ratio (μmol/l μmol) | 33 | 4.62 | 4.10 | 1.88 | 0.33 | 3.95 | 5.28 |
Tyrosine (μmol/l) | 32 | 85.43 | 81.49 | 19.12 | 3.38 | 78.53 | 92.32 |
Age (years) | 33 | 47.76 | 50.00 | 7.58 | 1.32 | 45.07 | 50.45 |
Time 2 (After Completion of Chemotherapy) | |||||||
Kynurenine (μmol/l) | 30 | 2.00 | 1.97 | 0.66 | 0.12 | 1.75 | 2.24 |
Tryptophan (μmol/l) | 30 | 48.14 | 49.82 | 10.81 | 1.97 | 44.11 | 52.18 |
Kyn/Trp ratio (μmol/l μmol) | 30 | 4.23 | 3.99 | 1.36 | 0.25 | 3.72 | 4.74 |
Tyrosine (μmol/l) | 30 | 86.44 | 83.99 | 20.76 | 3.79 | 78.69 | 94.19 |